pre-IPO PHARMA

regentys PRESS RELEASE ARCHIVE

Feb 19, 2019

Generex Biotechnology Subsidiary Regentys Corporation Receives Approval of Japanese Patent for Extracellular Matrix Hydrogel (Regentys ECMH™)


Jan 7, 2019

Generex Biotechnology Completes Acquisition of Regentys Corporation


Dec 14, 2018

Generex Biotechnology Partner Regentys Corporation Receives European Patent Approval for ECMH™ for Treatment of Ulcerative Colitis


Nov 29, 2018

Generex Biotechnology Expands Medical Device and Wound Care Portfolio with Acquisition of Regentys Corporation


Feb 14, 2018

Regentys, Cook Biotech to Collaborate in Developing, Delivering Unique Ulcerative Colitis Treatment



Jan 9, 2018

Regentys Names Dr. John F. Howes Vice President of Clinical and Regulatory Affairs


Google Analytics Alternative